• About
  • Subscribe
  • Advertise
  • Contact
Thursday, February 12, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home News

New ZEISS eye-screening device comes with advanced ‘multiple functionalities’

by Staff Writer
January 13, 2026
in Devices, Local, News, Ophthalmic equipment & diagnostics, Ophthalmic insights, Products
Reading Time: 3 mins read
A A
The ZEISS VISUREF 1000. Image: ZEISS.

The ZEISS VISUREF 1000. Image: ZEISS.

Share on FacebookShare on Twitter

ZEISS has announced the introduction of a versatile refraction device that combines wavefront autorefraction with multiple functionalities for comprehensive eye screening.

In a media release it said the ZEISS VISUREF 1000 broadened the range of services available to consumers, helping them to “protect and enhance their vision and visual health”.

The company said the VISUREF 1000 offered a variety of options for eyecare professionals and their customers as it combined essential tools to monitor both the anterior and posterior segments of the eye to detect a wide range of ocular pathologies.

The device integrated wavefront refraction, keratometry, pupillometry, corneal topography, tonometry and pachymetry into one comprehensive system and provides “advanced functions that allow for expanded services such as dry eye checks and contact lens fittings”, it said.

Also, the ZEISS VISUREF 1000 integrates technologies like a non-contact tonometer and a non- mydriatic fundus camera.

Dean Psarakis, optical product & training specialist at ZEISS Vision Care Australia and New Zealand, said: “Changing lifestyles, evolving habits, and an ageing population are contributing to a rise in eye conditions such as dry eye syndrome and cataracts.

“These trends emphasise the growing need for more advanced diagnostic tools to perform comprehensive eye check-ups.

“The ZEISS VISUREF 1000 empowers eyecare professionals to obtain detailed information about their patients’ eye health with the push of a button. This innovative device enables practitioners to expand their service offerings, provide personalised insights into eye health, and deliver tailored eyecare solutions that address the unique needs of each patient.”

ZEISS said the device employed advanced wavefront technology to account for both low- and high-order aberrations, so eyecare professionals could provide customers with a higher level of customisation in their lens prescriptions, such as lenses with ZEISS i.Scription technology, which reduces glare effects and improves visual brilliance, especially in low light, which leads to greater visual comfort for wearers and opens up upselling opportunities for eye care professionals.

For symptoms such as burning eyes and eye fatigue – synonymous with the increasing use of screens – ZEISS VISUREF 1000 allows for automated, non-invasive measurement of tear film break-up time (NIBUT) and provides the option to measure and analyse both the tear film quality and stability.

Additionally, a colour image with grading scales is used to assess the meibomian gland area and to measure the tear meniscus height.

ZEISS said the integrated fundus camera, non-contact tonometer and pachymeter significantly expanded screening capabilities.

High-resolution images of the retina and measurements of intraocular pressure as well as central corneal thickness could be generated with just a few clicks, it said.

“The device can be a starting point in the collaborative care journey of eyecare professionals and enables essential eye health screening measurements and services.”

Also, ZEISS VISUREF 1000 is “seamlessly connected” to the ZEISS ecosystem, allowing for centralised data management and communication between various ZEISS devices in the practice.

This enhanced efficiency and improved analytical capabilities, it said.

Related Posts

The retrospective study evaluated 58 children who had been born prematurely and followed for at least 12 months. Image: pop_thailand/stock.adobe.com

Study suggests HALT lenses may slow myopia in children born preterm

by Staff Writer
February 12, 2026

A new study has found that spectacle lenses using Highly Aspherical Lenslet Target (HALT) technology may slow the progression of...

The study looked at the impact of bacteria found in the eye. Image: Sokie/stock.adobe.com.

Study: Bacterium in retina linked to Alzheimer’s disease, cognitive decline

by Staff Writer
February 12, 2026

Researchers at Cedars-Sinai Medical Center in the US have established a link between bacterium in the retina and cognitive decline...

The system integrates a built-in PC and tiltable touch-screen display in a compact footprint. Image: BOC Instruments

BOC Instruments introduces automated AutoFusion OCT device

by Staff Writer
February 11, 2026

BOC Instruments has announced the release of a new Optovue optical coherence tomography (OCT) system, the AutoFusion, which combines OCT...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited